4
Changes in Ownership
RECURSION PHARMACEUTICALS, INC. Filed Acc 0001209191-23-035958
Chief Executive Officer sold 56,436 shares at $9.05 ($510,808)
- Chief Executive Officer acquired 31,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Gibson Christopher · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-06-07 | Exercise or conversion : show line 1 in the form | +31,250 | $2.48 | $77,500 | 972,814 | D |
| 2023-06-07 | Sale : show line 2 in the form | −56,436 | $9.05 | $510,808 | 916,378 | D |
| Open-market sales · 56,436 sh · avg $9.05 · $510,808 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2023-06-07 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −31,250 | $2.48 | 2030-12-30 | 31,250 | 593,750 | D |
Loading xslF345X04/doc4.xml…